4//SEC Filing
Turner Heather D 4
Accession 0001209191-22-020008
CIK 0001806952other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:11 PM ET
Size
5.3 KB
Accession
0001209191-22-020008
Insider Transaction Report
Form 4
Turner Heather D
Chief General Counsel
Transactions
- Award
Option (right to buy)
2022-03-16+300,000→ 300,000 totalExercise: $5.98Exp: 2032-03-15→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]12.5% of the option shares shall vest on August 9, 2022, with the remaining option shares to vest in equal monthly installments over the following forty-two months.
Documents
Issuer
Lyell Immunopharma, Inc.
CIK 0001806952
Entity typeother
Related Parties
1- filerCIK 0001403571
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 4:11 PM ET
- Size
- 5.3 KB